-+ 0.00%
-+ 0.00%
-+ 0.00%

Sobi's CEO to Exit in January 2027

MT Newswires·08/03/2026 01:30:37
语音播报
01:30 AM EDT, 08/03/2026 (MT Newswires) -- Swedish Orphan Biovitrum (SOBI.ST), or Sobi's, Chief Executive Officer Guido Oelkers will leave the company at the end of January 2027 to pursue an external opportunity. The Swedish pharmaceuticals company will launch the search process for Oelkers' successor immediately, according to a Monday release.